These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 5703273)

  • 1. [Syndrome of ovarian hyperstimulation with human gonadotropins].
    Mingeot R
    Bull Soc R Belge Gynecol Obstet; 1968; 38(2):133-44. PubMed ID: 5703273
    [No Abstract]   [Full Text] [Related]  

  • 2. [Risks of ovarian overstimulation by administration of clomiphene and gonadotropins for ovulation stimulation].
    Hammerstein J
    Geburtshilfe Frauenheilkd; 1967 Dec; 27(12):1125-51. PubMed ID: 5627491
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pleural effusion as a predominant manifestation of the ovarian hyperstimulation syndrome].
    Martí Ripoll S; Pahissa Berga A; Pigrau Serrallach C; Clotet Sala B; Bacardí Noguera R
    Med Clin (Barc); 1982 Nov 16-30; 79(9):419-21. PubMed ID: 7154738
    [No Abstract]   [Full Text] [Related]  

  • 4. [Lutein cyst formation of the ovaries with perforation and acute abdomen following HMG-HCG treatment].
    Friedrich F; Gitsch E
    Wien Klin Wochenschr; 1969 May; 81(18):318-20. PubMed ID: 5784062
    [No Abstract]   [Full Text] [Related]  

  • 5. Pretreatment with oral contraceptives in infertile anovulatory patients with polycystic ovary syndrome who receive gonadotropins for controlled ovarian stimulation.
    Palomba S; Falbo A; Orio F; Russo T; Tolino A; Zullo F
    Fertil Steril; 2008 Jun; 89(6):1838-42. PubMed ID: 17980363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovarian hyperstimulation syndrome.
    McArdle CR; Sacks BA
    AJR Am J Roentgenol; 1980 Oct; 135(4):835-6. PubMed ID: 6778122
    [No Abstract]   [Full Text] [Related]  

  • 7. The investigation and treatment of amenorrhea developing after treatment with oral contraceptives.
    Shearman RP; Mayes B
    Int J Fertil; 1968; 13(4):321-5. PubMed ID: 5700387
    [No Abstract]   [Full Text] [Related]  

  • 8. [The pill, amenorrhea and ovarian cysts. Conservative surgical treatment. Pregnancy].
    Paoli A; Masson JL
    Bull Fed Soc Gynecol Obstet Lang Fr; 1970; 22(1):90-2. PubMed ID: 5453571
    [No Abstract]   [Full Text] [Related]  

  • 9. [The syndrome of amenorrhea, galactorrhea and low secretion of gonadotropins].
    Servy E; Greenblatt RB; Scholer HF
    Bord Med; 1970 Dec; 3(12):2845-8 passim. PubMed ID: 5532782
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of oral contraceptives on assisted reproductive technology [corrected] cycles.
    Kolibianakis EM; Venetis CA; Tarlatzis BC
    Curr Opin Obstet Gynecol; 2007 Jun; 19(3):244-7. PubMed ID: 17495640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Medical and surgical treatment of functional ovarian cysts].
    Brun JL; Le Touzé O; Leng JJ
    J Gynecol Obstet Biol Reprod (Paris); 2001 Nov; 30(1 Suppl):S41-52. PubMed ID: 11917375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modern management of secondary amenorrhoea.
    Banerjee S
    Calcutta Med J; 1989; 86(5-6):46-9. PubMed ID: 12284231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemorrhagic ovarian cyst without peritoneal bleeding in a patient with ovarian hyperstimulation syndrome: case report.
    Kurioka H; Takahashi K; Kita N; Noda Y
    Chin Med J (Engl); 2005 Sep; 118(18):1577-81. PubMed ID: 16232339
    [No Abstract]   [Full Text] [Related]  

  • 14. Prolonged secondary amenorrhoea following the use of oral contraceptives.
    Greenhalf JO; Nota S
    Practitioner; 1972 Aug; 209(250):196-200. PubMed ID: 5078231
    [No Abstract]   [Full Text] [Related]  

  • 15. [The therapeutic use of the sequentially administered oral ovulation inhibitor Ovanon].
    Gimes R; Tóth F
    Dtsch Med J; 1969 Dec; 20(23):718-9. PubMed ID: 5397037
    [No Abstract]   [Full Text] [Related]  

  • 16. [Polycystic ovaries on both sides caused by overstimulation with gonadotropins].
    Feige A
    Med Klin; 1980 Feb; 75(4):56,62. PubMed ID: 7374619
    [No Abstract]   [Full Text] [Related]  

  • 17. [Colpocytology in evaluation of treatment with human gonadotropins (HMG)].
    Minucci D; Ambrosini A; Pelusi G
    Atti Accad Fisiocrit Siena Med Fis; 1968; 17(2):883-96. PubMed ID: 5760334
    [No Abstract]   [Full Text] [Related]  

  • 18. Management of ovarian hyperstimulation due to follicle-stimulating hormone-secreting gonadotroph adenoma.
    Murakami T; Higashitsuji H; Yoshinaga K; Terada Y; Ito K; Ikeda H
    BJOG; 2004 Nov; 111(11):1297-300. PubMed ID: 15521879
    [No Abstract]   [Full Text] [Related]  

  • 19. [Ovarian dysfunction after discontinuance of oral contraceptives (author's transl)].
    Sas M; Kincses L; Resch B
    Geburtshilfe Frauenheilkd; 1974 Jun; 34(6):460-3. PubMed ID: 4849334
    [No Abstract]   [Full Text] [Related]  

  • 20. Short coasting of 1 or 2 days by withholding both gonadotropins and gonadotropin-releasing hormone agonist prevents ovarian hyperstimulation syndrome without compromising the outcome.
    Moon HS; Joo BS; Moon SE; Lee SK; Kim KS; Koo JS
    Fertil Steril; 2008 Dec; 90(6):2172-8. PubMed ID: 18439601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.